Endogenous galectins and the control of the host inflammatory response

Journal of Endocrinology

Volumn 201, Issue 2, 2009, Pages 169-184

  Norling, Lucy V ^a   Perretti, Mauro ^a   Cooper, Dianne ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD4 ANTIGEN; CD7 ANTIGEN; ECALECTIN; FIBRONECTIN; GALECTIN; GALECTIN 1; GALECTIN 3; GAMMA INTERFERON; GANGLIOSIDE GM1; HERMES ANTIGEN; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LAMININ; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MUCIN 1; PROTEIN PTPRC; PROTEIN TYROSINE PHOSPHATASE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4; ANTIINFLAMMATORY AGENT; AUTACOID;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; ASTHMA; AUTOIMMUNITY; CELL ACTIVATION; CELLULAR IMMUNITY; CHRONIC DISEASE; COLITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE OVEREXPRESSION; HEPATITIS; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; NEPHRITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONITIS; PHARMACOLOGICAL BLOCKING; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UVEITIS; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; GALECTINS; HUMANS; IMMUNE SYSTEM PROCESSES; INFLAMMATION; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL;

EID: 67650708852     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0512     Document Type: Review

References (154)

1. Akahani S, Nangia-Makker P, Inohara H, Kim HR & Raz A 1997 Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Research 57 5272-5276.
2. Allione A, Wells V, Forni G, Mallucci L & Novelli F 1998 Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes. Journal of Immunology 161 2114-2119.
3. Almkvist J, Dahlgren C, Leffler H & Karlsson A 2002 Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1. Journal of Immunology 168 4034-4041.
4. Amano M, Galvan M, He J & Baum LG 2003 The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. Journal of Biological Chemistry 278 7469-7475.
5. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Nishi N, Imaizumi T et al. 2002 Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. Journal of Immunology 169 5912-5918.
6. Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS & Makino H 2005 Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms. Journal of the American Society of Nephrology 16 3222-3234.
7. Balasubramanian K, Vasudevamurthy R, Venkateshaiah SU, Thomas A, Vishweshwara A & Dharmesh SM 2008 Galectin-3 in urine of cancer patients: stage and tissue specificity. Journal of Cancer Research and Clinical Oncology 19 16-20.
8. Barondes SH, Cooper DN, Gitt MA & Leffler H 1994 Structure and function of a large family of animal lectins. Journal of Biological Chemistry 269 20807-20810.
9. Baum LG, Pang M, Perillo NL, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M & Seilhamer JJ 1995a Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. Journal of Experimental Medicine 181 877-887.
10. Baum LG, Seilhamer JJ, Pang M, Levine WB, Beynon D & Berliner JA 1995 b Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation. Glycoconjugate Journal 12 63-68.
11. Bernardes ES, Silva NM, Ruas LP, Mineo JR, Loyola AM, Hsu DK, Liu FT, Chammas R & Roque-Barreira MC 2006 Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. American Journal of Pathology 168 1910-1920.
12. Bi S, Earl LA, Jacobs L & Baum LG 2008 Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. Journal of Biological Chemistry 283 12248-12258.
13. Blaser C, Kaufmann M, Muller C, Zimmermann C, Wells V, Mallucci L & Pircher H 1998 Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. European Journal of Immunology 28 2311-2319.
14. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B et al. 2007 A pivotal role for galectin-1 in fetomaternal tolerance. Nature Medicine 13 1450-1457.
15. Breuilh L, Vanhoutte F, Fontaine J, van Stijn CM, Tillie-Leblond I, Capron M, Faveeuw C, Jouault T, van Die I, Gosset P et al. 2007 Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infection and Immunity 75 5148-5157.
16. Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA & Stitt AW 2007 Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Experimental Diabetes Research 2007 51837.
17. Case D, Irwin D, Ivester C, Harral J, Morris K, Imamura M, Roedersheimer M, Patterson A, Carr M, Hagen M et al. 2007 Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology 292 L154-L164.
18. Cho M & Cummings RD 1995 Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells, II. Localization and biosynthesis. Journal of Biological Chemistry 270 5207-5212.
19. Colnot C, Fowlis D, Ripoche MA, Bouchaert I & Poirier F 1998a Embryonic implantation in galectin 1/galectin 3 double mutant mice. Developmental Dynamics 211 306-313.
20. Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR & Poirier F 1998b Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 94 290-296.
21. Cooper DN & Barondes SH 1999 God must love galectins; he made so many of them. Glycobiology 9 979-984.
22. Cooper D, Norling LV & Perretti M 2008 Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow. Journal of Leukocyte Biology 83 1459-1466.
23. Correa SG, Sotomayor CE, Aoki MP, Maldonado CA & Rabinovich GA 2003 Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages. Glycobiology 13 119-128.
24. Cortegano I, del Pozo V, Cardaba B, de Andres B, Gallardo S, del Amo A, Arrieta I, Jurado A, Palomino P, Liu FT et al. 1998 Galectin-3 down-regulates IL-5 gene expression on different cell types. Journal of Immunology 161 385-389.
25. Craig SS, Krishnaswamy P, Irani AM, Kepley CL, Liu FT & Schwartz LB 1995 Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils. Anatomical Record 242 211-219.
26. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, Abe H, Katoh S, Kontani K, Kihara M, Zhang SL et al. 2005 Galectin-9 induces maturation of human monocyte-derived dendritic cells. Journal of Immunology 175 2974-2981.
27. DeGrendele HC, Estess P, Picker LJ & Siegelman MH 1996 CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. Journal of Experimental Medicine 183 1119-1130.
28. DeGrendele HC, Estess P & Siegelman MH 1997 Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278 672-675.
29. Demetriou M, Granovsky M, Quaggin S & Dennis JW 2001 Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 733-739.
30. Dias-Baruffi M, Zhu H, Cho M, Karmakar S, McEver RP & Cummings RD 2003 Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. Journal of Biological Chemistry 278 41282-41293.
31. Elola MT, Chiesa ME, Alberti AF, Mordoh J & Fink NE 2005 Galectin-1 receptors in different cell types. Journal of Biomedical Science 12 13-29.
32. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR & Rabinovich GA 2007 Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cellular and Molecular Life Sciences 64 1679-1700.
33. English NM, Lesley JF & Hyman R 1998 Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Research 58 3736-3742.
34. Fajka-Boja R, Blasko A, Kovacs-Solyom F, Szebeni GJ, Toth GK & Monostori E 2008 Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis. Cellular and Molecular Life Sciences 65 2586-2593.
35. Farnworth SL, Henderson NC, Mackinnon AC, Atkinson KM, Wilkinson T, Dhaliwal K, Hayashi K, Simpson AJ, Rossi AG, Haslett C et al. 2008
36. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. American Journal of Pathology 172 395-405.
37. Feigelson SW, Grabovsky V, Winter E, Chen LL, Pepinsky RB, Yednock T, Yablonski D, Lobb R & Alon R 2001 The Src kinase p56(lck) up-regulates VLA-4 integrin affinity, Implications for rapid spontaneous and chemokine- triggered T cell adhesion to VCAM-1 and fibronectin. Journal of Biological Chemistry 276 13891-13901.
38. Fernandez GC, Ilarregui JM, Rubel CJ, Toscano MA, Gomez SA, Beigier Bompadre M, Isturiz MA, Rabinovich GA & Palermo MS 2005 Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 15 519-527.
39. Feuk-Lagerstedt E, Jordan ET, Leffler H, Dahlgren C & Karlsson A 1999 Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils. Journal of Immunology 163 5592-5598.
40. Flotte TJ, Springer TA & Thorbecke GJ 1983 Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. American Journal of Pathology 111 112-124.
41. Fouillit M, Joubert-Caron R, Poirier F, Bourin P, Monostori E, Levi-Strauss M, Raphael M, Bladier D & Caron M 2000 Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 10 413-419.
42. Frigeri LG, Zuberi RI & Liu FT 1993 Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry 32 7644-7649.
43. Fuertes MB, Molinero LL, Toscano MA, Ilarregui JM, Rubinstein N, Fainboim L, Zwirner NW & Rabinovich GA 2004 Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Molecular and Cellular Biochemistry 267 177-185.
44. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S & Raz A 2003 CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Research 63 8302-8311.
45. Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R & Lechler RI 2007 Galectin-1: a key effector of regulation mediated by CD4+ CD25+T cells. Blood 109 2058-2065.
46. Gil CD, Cooper D, Rosignoli G, Perretti M & Oliani SM 2006a Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis. Inflammation Research 55 99-107.
47. Gil CD, La M, Perretti M & Oliani SM 2006b Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3. Cell Biology International 30 338-344.
48. Gilroy DW, Lawrence T, Perretti M & Rossi AG 2004 Inflammatory resolution: new opportunities for drug discovery. Nature Reviews. Drug Discovery 3 401-416.
49. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL & Quinn TP 2001 The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Research 61 4851-4857.
50. Harjacek M, Diaz-Cano S, De Miguel M, Wolfe H, Maldonado CA & Rabinovich GA 2001 Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. Journal of Rheumatology 28 1914-1922.
51. He J & Baum LG 2006 Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Laboratory Investigation 86 578-590.
52. Hernandez JD & Baum LG 2002 Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 12 127R-136R.
53. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE et al. 2002 Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochemica and Biophysica Acta 1572 232-254.
54. Ho MK & Springer TA 1982 Mac-2, a novel 32 000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. Journal of Immunology 128 1221-1228.
55. Houzelstein D, Goncalves IR, Fadden AJ, Sidhu SS, Cooper DN, Drickamer K, Leffler H & Poirier F 2004 Phylogenetic analysis of the vertebrate galectin family. Molecular Biology and Evolution 21 1177-1187.
56. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP & Liu FT 2000 Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. American Journal of Pathology 156 1073-1083.
57. Hughes RC 2001 Galectins as modulators of cell adhesion. Biochimie 83 667-676.
58. Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C et al. 2004 Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB Journal 18 1773-1775.
59. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Nishi N, Fujimoto K, Tanji K, Shibata T et al. 2002 Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. Journal of Leukocyte Biology 72 486-491.
60. Inohara H, Segawa T, Miyauchi A, Yoshii T, Nakahara S, Raz A, Maeda M, Miyoshi E, Kinoshita N, Yoshida H et al. 2008 Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies. Biochemical and Biophysical Research Communication 376 605-610.
61. Jeng KC, Frigeri LG & Liu FT 1994 An endogenous lectin, galectin-3 (epsilon BP/Mac-2), potentiates IL-1 production by human monocytes. Immunology Letters 42 113-116.
62. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W & Eberlein TJ 2001 Expression and function of galectin-3, a beta-galactosidebinding protein in activated T lymphocytes. Journal of Leukocyte Biology 69 555-564.
63. Jouault T, El Abed-El Behi M, Martinez-Esparza M, Breuilh L, Trinel PA, Chamaillard M, Trottein F & Poulain D 2006 Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. Journal of Immunology 177 4679-4687.
64. Karlsson A, Christenson K, Matlak M, Bjorstad A, Brown KL, Telemo E, Salomonsson E, Leffler H & Bylund J 2008 Galectin-3 functions as an opsonin and enhances macrophage clearance of apoptotic neutrophils. Glycobiology 135 355-363.
65. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T & Hirashima M 2003 Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. Journal of Immunology 170 3631-3636.
66. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, Shinonaga R, Niki T, Nishi N, Tominaga A, Yamauchi A et al. 2007 Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. American Journal of Respiratory and Critical Care Medicine 176 27-35.
67. Kuwabara I & Liu FT 1996 Galectin-3 promotes adhesion of human neutrophils to laminin. Journal of Immunology 156 3939-3944.
68. La M, Cao TV, Cerchiaro G, Chilton K, Hirabayashi J, Kasai K, Oliani SM, Chernajovsky Y & Perretti M 2003 A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. American Journal of Pathology 163 1505-1515.
69. van der Leij J, van den Berg A, Blokzijl T, Harms G, van Goor H, Zwiers P, van Weeghel R, Poppema S & Visser L 2004 Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. Journal of Pathology 204 511-518.
70. van der Leij J, van den Berg A, Harms G, Eschbach H, Vos H, Zwiers P, van Weeghel R, Groen H, Poppema S & Visser L 2007 Strongly enhanced IL-10 production using stable galectin-1 homodimers. Molecular Immunology 44 506-513.
71. Levi G, Tarrab-Hazdai R & Teichberg VI 1983 Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. European Journal of Immunology 13 500-507.
72. Li Y, Komai-Koma M, Gilchrist DS, Hsu DK, Liu FT, Springall T & Xu D 2008 Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. Journal of Immunology 181 2781-2789.
73. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY & Henderson WR Jr 1995 Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. American Journal of Pathology 147 1016-1028.
74. Liu FT, Patterson RJ & Wang JL 2002 Intracellular functions of galectins. Biochemica and Biophysica Acta 1572 263-273.
75. Liu FT & Rabinovich GA 2005 Galectins as modulators of tumour progression. Nature Review Cancer 5 29-41.
76. Liu SD, Whiting CC, Tomassian T, Pang M, Bissel SJ, Baum LG, Mossine VV, Poirier F, Huflejt ME & Miceli MC 2008 Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood 112 120-130.
77. Lopez E, del Pozo V, Miguel T, Sastre B, Seoane C, Civantos E, Llanes E, Baeza ML, Palomino P, Cardaba B et al. 2006 Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. Journal of Immunology 176 1943-1950.
78. Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC & Nicolson GL 1994 Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconjugate Journal 11 462-468.
79. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ & Sethi T 2008 Regulation of alternative macrophage activation by galectin-3. Journal of Immunology 180 2650-2658.
80. Manjunath N, Correa M, Ardman M & Ardman B 1995 Negative regulation of T-cell adhesion and activation by CD43. Nature 377 535-538.
81. Matsuda Y, Yamagiwa Y, Fukushima K, Ueno Y & Shimosegawa T 2008 Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Hepatology Research 38 1098-1111.
82. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL & Hirashima M 1998 Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. Journal of Biological Chemistry 273 16976-16984.
83. Matsumoto R, Hirashima M, Kita H & Gleich GJ 2002 Biological activities of ecalectin: a novel eosinophil-activating factor. Journal of Immunology 168 1961-1967.
84. Mey A, Leffler H, Hmama Z, Normier G & Revillard JP 1996 The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. Journal of Immunology 156 1572-1577.
85. Mok SW, Riemer C, Madela K, Hsu DK, Liu FT, Gultner S, Heise I & Baier M 2007 Role of galectin-3 in prion infections of the CNS. Biochemical and Biophysical Research Communication 359 672-678.
86. Moon BK, Lee YJ, Battle P, Jessup JM, Raz A & Kim HR 2001 Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. American Journal of Pathology 159 1055-1060.
87. Mustelin T, Vang T & Bottini N 2005 Protein tyrosine phosphatases and the immune response. Nature Reviews Immunology 5 43-57.
88. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ & Raz A 2000 Galectin-3 induces endothelial cell morphogenesis and angiogenesis. American Journal of Pathology 156 899-909.
89. Nieminen J, St-Pierre C & Sato S 2005 Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. Journal of Leukocyte Biology 78 1127-1135.
90. Nieminen J, St-Pierre C, Bhaumik P, Poirier F & Sato S 2008 Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. Journal of Immunology 180 2466-2473.
91. Nobumoto A, Nagahara K, Oomizu S, Katoh S, Nishi N, Takeshita K, Niki T, Tominaga A, Yamauchi A & Hirashima M 2008 Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 18 735-744.
92. Nomoto K, Tsuneyama K, Abdel Aziz HO, Takahashi H, Murai Y, Cui ZG, Fujimoto M, Kato I, Hiraga K, Hsu DK et al. 2006 Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice. Journal of Pathology 210 469-477.
93. Norling LV, Sampaio AL, Cooper D & Perretti M 2008 Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. FASEB Journal 22 682-690.
94. Offner H, Celnik B, Bringman TS, Casentini-Borocz D, Nedwin GE & Vandenbark AA 1990 Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 28 177-184.
95. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S et al. 2003 Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 48 2788-2795.
96. Ozeki Y, Matsui T, Yamamoto Y, Funahashi M, Hamako J & Titani K 1995 Tissue fibronectin is an endogenous ligand for galectin-1. Glycobiology 5 255-261.
97. Pace KE, Hahn HP, Pang M, Nguyen JT & Baum LG 2000 CD7, delivers a pro-apoptotic signal during galectin-1-induced T cell death. Journal of Immunology 165 2331-2334.
98. Pacienza N, Pozner RG, Bianco GA, D'Atri LP, Croci DO, Negrotto S, Malaver E, Gomez RM, Rabinovich GA & Schattner M 2008 The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation. FASEB Journal 22 1113-1123.
99. Park JW, Voss PG, Grabski S, Wang JL & Patterson RJ 2001 Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res 29 3595-3602.
100. Peppa M, Brem H, Ehrlich P, Zhang JG, CaiW, Li Z, Croitoru A, Thung S & Vlassara H 2003 Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52 2805-2813.
101. Perillo NL, Pace KE, Seilhamer JJ & Baum LG 1995 Apoptosis of T cells mediated by galectin-1. Nature 378 736-739.
102. Perillo NL, Uittenbogaart CH, Nguyen JT & Baum LG 1997 Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. Journal of Experimental Medicine 185 1851-1858.
103. Perone MJ, Bertera S, Tawadrous ZS, Shufesky WJ, Piganelli JD, Baum LG, Trucco M & Morelli AE 2006 Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. Journal of Immunology 177 5278-5289.
104. Poirier F & Robertson EJ 1993 Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 119 1229-1236.
105. del Pozo MA, Cabanas C, Montoya MC, Ager A, Sanchez-Mateos P & Sanchez-Madrid F 1997 ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 137 493-508.
106. Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu FT et al. 2001 Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB Journal 15 2471-2479.
107. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM & Sotomayor CE 1998 Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. Journal of Immunology 160 4831-4840.
108. Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai KI & Lider O 1999a Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 97 100-106.
109. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J & Chernajovsky Y 1999b Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. Journal of Experimental Medicine 190 385-398.
110. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I & Correa SG 2000 Evidence of a role for galectin-1 in acute inflammation. European Journal of Immunology 30 1331-1339.
111. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT & Iacobelli S 2002 Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23 313-320.
112. Raz A & Lotan R 1987 Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6 433-452.
113. Saegusa J, Hsu DK, Liu W, Kuwabara I, Kuwabara Y, Yu L & Liu FT 2008 Galectin-3 protects keratinocytes from UVB-induced apoptosis by enhancing AKT activation and suppressing ERK activation. J Invest Dermatol 128 2403-2411.
114. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M & Liu FT 2000 Human galectin-3 is a novel chemoattractant for monocytes and macrophages. Journal of Immunology 165 2156-2164.
115. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S & Liu FT 2003 Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112 389-397.
116. Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B & Morelli A 2000 Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31 399-406.
117. Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA & Morelli A 2003 Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124 1381-1394.
118. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A & Bergeron MG 2002 Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. Journal of Immunology 168 1813-1822.
119. Saussez S, Decaestecker C, Mahillon V, Cludts S, Capouillez A, Chevalier D, Vet HK, Andre S, Toubeau G, Leroy X et al. 2008 Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope 118 1583-1590.
120. Scott K & Weinberg C 2004 Galectin-1: a bifunctional regulator of cellular proliferation. Glycoconjugate Journal 19 467-477.
121. Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, Nobumoto A, Niki T, Saita N, Ito K et al. 2007 Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 56 3968-3976.
122. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N et al. 2008 Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127 78-88.
123. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG & Wallace JL 2007 Resolution of inflammation: state of the art, definitions and terms. FASEB Journal 21 325-332.
124. Silva-Monteiro E, Reis Lorenzato L, Kenji Nihei O, Junqueira M, Rabinovich GA, Hsu DK, Liu FT, Savino W, Chammas R & Villa-Verde DM 2007 Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. American Journal of Pathology 170 546-556.
125. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT & Baum LG 2006 Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. Journal of Immunology 176 778-789.
126. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR & Gardiner TA 2005 Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 54 785-794.
127. Stowell SR, Qian Y, Karmakar S, Koyama NS, Dias-Baruffi M, Leffler H, McEver RP & Cummings RD 2008 Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. Journal of Immunology 180 3091-3102.
128. Streuli C 1999 Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 11 634-640.
129. Suzuki Y, Inoue T, Yoshimaru T & Ra C 2008 Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition. Biochemica and Biophysica Acta 1783 924-934.
130. Symons A, Cooper DN & Barclay AN 2000 Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1. Glycobiology 10 559-563.
131. Taipale J & Keski-Oja J 1997 Growth factors in the extracellular matrix. FASEB Journal 11 51-59.
132. Than NG, Erez O, Wildman DE, Tarca AL, Edwin SS, Abbas A, Hotra J, Kusanovic JP, Gotsch F, Hassan SS et al. 2008 Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neonatal Med 21 429-442.
133. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J et al. 2006 Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. PNAS 103 15975-15980.
134. Thijssen VL, Poirier F, Baum LG & Griffioen AW 2007 Galectins in the tumor endothelium: opportunities for combined cancer therapy. Blood 110 2819-2827.
135. Toscano MA, Commodaro AG, Ilarregui JM, Bianco GA, Liberman A, Serra HM, Hirabayashi J, Rizzo LV & Rabinovich GA 2006 Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. Journal of Immunology 176 6323-6332.
136. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD, Zwirner NW, Poirier F, Riley EM, Baum LG et al. 2007 Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8 825-834.
137. Truong MJ, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A & Capron M 1993 Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. Journal of Experimental Medicine 177 243-248.
138. Tsuboi Y, Abe H, Nakagawa R, Oomizu S, Watanabe K, Nishi N, Nakamura T, Yamauchi A & Hirashima M 2007 Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin Immunol 124 221-233.
139. Tsuchiyama Y, Wada J, Zhang H, Morita Y, Hiragushi K, Hida K, Shikata K, Yamamura M, Kanwar YS & Makino H 2000 Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int 58 1941-1952.
140. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT & Cerami A 1995 Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1 634-646.
141. Vyakarnam A, Dagher SF, Wang JL & Patterson RJ 1997 Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol 17 4730-4737.
142. Wada J, Ota K, Kumar A, Wallner EI & Kanwar YS 1997 Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99 2452-2461.
143. Walzel H, Schulz U, Neels P & Brock J 1999 Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunology Letters 67 193-202.
144. Wang JL, Gray RM, Haudek KC & Patterson RJ 2004 Nucleocytoplasmic lectins. Biochemica and Biophysica Acta 1673 75-93.
145. Wang F, He W, Zhou H, Yuan J, Wu K, Xu L & Chen ZK 2007 The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell Immunol 250 68-74.
146. Yamamoto H, Kashio Y, Shoji H, Shinonaga R, Yoshimura T, Nishi N, Nabe T, Nakamura T, Kohno S & Hirashima M 2007 Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol 143 (Supplement 1) 95-105.
147. Yamaoka A, Kuwabara I, Frigeri LG & Liu FTA 1995 A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. Journal of Immunology 154 3479-3487.
148. Yang RY, Hsu DK & Liu FT 1996 Expression of galectin-3 modulates T-cell growth and apoptosis. PNAS 93 6737-6742.
149. Yang RY, Rabinovich GA & Liu FT 2008 Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10 e17.
150. Yu F, Finley RL Jr, Raz A & Kim 2002 Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. Journal of Biological Chemistry 277 15819-15827.
151. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J & Kasai K 2007 Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. Journal of Biological Chemistry 282 773-781.
152. Zhou Q & Cummings RD 1993 L-14, lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys 300 6-17.
153. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB & Kuchroo VK 2005 The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 1245-1252.
154. Zuberi RI, Hsu DK, Kalayci O, Chen HY, Sheldon HK, Yu L, Apgar JR, Kawakami T, Lilly CM & Liu FT 2004 Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. American Journal of Pathology 165 2045-2053.